Can You Take Ashwagandha With Antidepressants?
Ashwagandha (Withania somnifera) has become one of the most popular adaptogenic herbs out there, especially among people looking for natural support with stress and anxiety. And many of those people are already taking prescription antidepressants. So the question comes up a lot: is it safe to combine them? In this guide, we dig into the clinical evidence for potential interactions, flag which combinations call for extra caution, and give you practical talking points for your next conversation with your healthcare provider.
Key Takeaways
- ✓Ashwagandha has no well-documented dangerous interactions with most SSRIs at standard doses, but clinical data remains limited.
- ✓The combination may produce additive sedation, particularly with tricyclic antidepressants and trazodone.
- ✓Ashwagandha may modulate thyroid hormones, which can affect patients taking levothyroxine alongside antidepressants.
- ✓The MAOI combination is generally considered contraindicated in clinical literature due to theoretical serotonergic risk.
- ✓Many healthcare providers prefer to be informed about all supplements their patients are taking, including ashwagandha, especially alongside an antidepressant regimen.
1. What Is Ashwagandha and How Does It Work?
Ashwagandha has been a cornerstone of Ayurvedic medicine for thousands of years. It is classified as a rasayana, a rejuvenative tonic believed to promote longevity and vitality. Ashwagandha has earned its reputation over centuries of traditional use, and modern research is beginning to catch up. In pharmacological terms, its primary active compounds arewithanolides (the main active compounds that give ashwagandha its effects), a group of steroidal lactones that influence several biological pathways related to stress and mood.
The mechanisms most relevant to antidepressant interactions include:
- HPA axis modulation. Ashwagandha reduces cortisol output by attenuating the hypothalamic-pituitary-adrenal axis. A 2019 randomized controlled trial published in Medicine found that 240 mg of standardized extract reduced serum cortisol by 23% compared to placebo over eight weeks.
- GABAergic activity. Withanolides act as positive allosteric modulators at GABA-A receptors, producing mild calming and sedative effects. In simpler terms, they work on the same brain receptors as benzodiazepines like Valium, just much more gently.
- Serotonin modulation. Animal studies demonstrate that ashwagandha increases serotonin levels in the prefrontal cortex and hippocampus, likely through modulation of tryptophan hydroxylase activity rather than reuptake inhibition.
- Thyroid hormone stimulation. Ashwagandha has been shown to increase serum T3 and T4 levels, a property that becomes clinically significant in patients taking thyroid-sensitive medications.
These overlapping mechanisms, particularly the serotonin and GABA activity, are exactly why the question of combining ashwagandha with antidepressants deserves a closer look. Let's go through each antidepressant class one at a time.
2. Ashwagandha and SSRIs
Selective serotonin reuptake inhibitors, including sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), citalopram (Celexa), and paroxetine (Paxil), are the most commonly prescribed antidepressant class worldwide. The good news is that the interaction profile with ashwagandha is generally regarded as low risk, but not zero risk.
What the Evidence Shows
No published case reports document serotonin syndrome or other severe adverse events from combining ashwagandha with an SSRI. That is reassuring, but it is worth noting that the absence of reported problems does not automatically mean the combination is proven safe. Herb-drug interactions are systematically underreported in the systems that track supplement side effects, so gaps in the data are common.
The theoretical concern centers on additive serotonin effects (where both substances increase serotonin, and the combined effect is stronger than either alone). Ashwagandha does not block serotonin reuptake the way SSRIs do. Instead, it appears to boost serotonin production through a different pathway. The result? Your overall serotonin levels could end up higher than what either one would produce on its own.
Practical Risk Assessment
So what does this mean in practice? For most people on a standard SSRI dose, ashwagandha at typical supplemental doses (300 to 600 mg of standardized root extract daily) is unlikely to trigger serotonin syndrome (a serious condition where serotonin levels get dangerously high). The risk goes up with:
- High-dose SSRI therapy (e.g., fluoxetine 60 mg or above)
- Concurrent use of other serotonergic agents (triptans, tramadol, St. John's Wort)
- High-dose ashwagandha supplementation (above 1,000 mg daily)
- Genetic variations in the CYP2D6 enzyme that make your body slower at breaking down SSRIs
Here's where it gets important: When people do combine these with their doctor's knowledge, studies have typically started at around 300 mg daily and increased gradually. Watch for agitation, confusion, rapid heart rate, dilated pupils, or muscle twitching. These are recognized warning signs of serotonin syndrome, a condition that healthcare providers treat as a medical emergency.
3. Ashwagandha and SNRIs
Serotonin-norepinephrine reuptake inhibitors, principally venlafaxine (Effexor) and duloxetine (Cymbalta), carry a somewhat higher interaction risk than SSRIs. Why? Because they affect both serotonin and norepinephrine systems, which means more overlap with what ashwagandha does.
Ashwagandha's cortisol-lowering effects indirectly influence norepinephrine signaling, since cortisol and norepinephrine are closely linked through your body's stress response. In theory, combining them could lead to extra sedation or blood pressure changes. That said, these effects have not actually been documented in clinical studies at standard doses, which is encouraging.
The sedation risk is the main practical concern here. Both SNRIs (especially when you first start them) and ashwagandha can make you drowsy. So if you are combining them for the first time, be careful with driving and anything that requires sharp focus until you know how the combination affects you.
4. Ashwagandha and Tricyclic Antidepressants
Tricyclic antidepressants (TCAs), including amitriptyline, nortriptyline, imipramine, and doxepin, present a more complex picture. TCAs are broad-acting medications that affect serotonin, norepinephrine, histamine, and acetylcholine receptors all at once. That broad activity is what gives them their significant sedation and anticholinergic side effects (dry mouth, blurred vision, constipation).
Here's the key concern: the additive sedation from ashwagandha's calming GABA effects layered on top of TCAs' antihistamine-related drowsiness. Together, they can make you much sleepier than either one alone. This combination calls for extra caution, especially for older adults or anyone taking other sedating medications.
Bottom line: If you are on a TCA and want to try ashwagandha, this is one where you really should have your doctor in the loop. Clinical practice typically involves conservative dosing, and your prescriber will want to keep an eye on how sedated you are feeling overall.
5. Ashwagandha and MAOIs
Monoamine oxidase inhibitors, including phenelzine (Nardil), tranylcypromine (Parnate), and selegiline, have the most restrictive interaction profiles of any antidepressant class. This is the section where we need to be most careful. MAOIs work by preventing your body from breaking down serotonin, norepinephrine, and dopamine. That means anything else that raises those brain chemicals could potentially trigger a hypertensive crisis (dangerously high blood pressure) or serotonin syndrome.
Given ashwagandha's documented effects on serotonin production and its influence on stress hormone signaling, this combination is generally considered inadvisable. No case reports of adverse events exist, partly because MAOIs are rarely prescribed these days, which makes real-world data scarce. But the pharmacological reasoning for concern is strong enough that most practitioners would advise against it.
6. The Thyroid Connection
This is one that a lot of people miss. A frequently overlooked piece of the ashwagandha-antidepressant puzzle involves thyroid function. Subclinical hypothyroidism (a mildly underactive thyroid that may not cause obvious symptoms) is a known contributor to treatment-resistant depression, and many people take levothyroxine for it alongside their antidepressant.
Ashwagandha has been demonstrated to increase serum T4 and T3 levels in multiple clinical trials, including a 2018 study in the Journal of Alternative and Complementary Medicine that documented a 19.6% increase in T4 among subjects with subclinical hypothyroidism over eight weeks.
For people on levothyroxine, this thyroid-boosting effect could shift hormone levels enough to require a dose adjustment. And here is the part that really matters: abrupt changes in thyroid status can destabilize your mood, potentially undermining what your antidepressant is doing or even mimicking anxiety symptoms. That can be confusing and distressing if you do not know what is causing it.
What you can do: If you are taking levothyroxine and an antidepressant and want to add ashwagandha, ask your doctor about checking your thyroid levels (TSH and free T4) before you start, and then again after six to eight weeks. That way you will catch any shifts early.
7. Dosage and Timing Considerations
If you and your healthcare provider decide the combination makes sense for you, here are some practical ways to minimize risk:
- Start low. Standard supplemental doses reported in the literature range from 300 to 600 mg of a standardized root extract (typically standardized to 5% withanolides), with many studies beginning at the lower end of this range.
- Separate timing. Take ashwagandha at a different time of day than your antidepressant to avoid peak-concentration overlap. If your antidepressant is a morning pill, consider taking ashwagandha in the evening. Its mild sedative quality may even help with sleep.
- Avoid escalation without guidance. Some practitioners advise against increasing ashwagandha dosage without consulting a prescriber, particularly when adjusting antidepressant doses simultaneously.
- Monitor for two weeks. Most interactions, if they are going to show up, will do so within the first 14 days. Keep an eye out for unusual agitation, excessive drowsiness, stomach issues, or mood changes during this window.
- Choose reputable products. Contamination and mislabeling are common in the supplement industry. Use products that carry third-party testing certifications (USP, NSF, or ConsumerLab).
8. When to Avoid the Combination Entirely
There are some situations where combining ashwagandha and antidepressants is generally considered a no-go:
- You are taking an MAOI or have discontinued one within the past 14 days
- You are taking multiple serotonergic medications (e.g., an SSRI plus a triptan or tramadol)
- You have a history of serotonin syndrome
- You have hyperthyroidism or Graves' disease
- You are pregnant or breastfeeding (ashwagandha is classified as potentially abortifacient in traditional texts)
- You are scheduled for surgery within two weeks (ashwagandha may potentiate anesthetic sedation)
9. How to Discuss Ashwagandha With Your Doctor
We get it. A lot of people hesitate to bring up supplements with their doctor, sometimes because they worry about being dismissed. But an honest conversation is essential for your safety, and most providers genuinely want to know. Here are a few ways to make that conversation easier:
- Frame it clinically. Rather than asking “is ashwagandha okay?”, try: “I've been reading about ashwagandha's effects on cortisol and GABAergic activity. Given my current medication regimen, are there any pharmacological concerns with adding it?”
- Bring the product label. Your prescriber needs to know the specific extract type, dose, and standardization, since not all ashwagandha products are equivalent.
- Propose a monitoring plan. Suggesting a two-week check-in demonstrates that you take the interaction question seriously and invites collaborative decision-making.
Sources & Further Reading
- Lopresti AL, Smith SJ, Malvi H, Kodgule R. "An investigation into the stress-relieving and pharmacological actions of an ashwagandha extract." Medicine. 2019;98(37).
- Candelario M, et al. "Direct evidence for GABAergic activity of Withania somnifera on mammalian ionotropic GABA-A and GABA-rho receptors." J Ethnopharmacol. 2015;171:264-272.
- Sharma AK, Basu I, Singh S. "Efficacy and safety of ashwagandha root extract in subclinical hypothyroid patients." J Altern Complement Med. 2018;24(3):243-248.
- Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." J Altern Complement Med. 2014;20(12):901-908.
- Natural Medicines Comprehensive Database. "Ashwagandha Monograph." Therapeutic Research Center.
This article synthesizes findings from peer-reviewed research, pharmacological databases, and clinical monographs. It is intended for educational purposes and does not constitute medical advice.
Check your specific combination
Enter your antidepressant and any supplements you're considering into our free Interaction Checker.
Open Interaction Checker